Ryman Healthcare

Ryman Healthcare, based in New Zealand and operating in the Health and social work services sector, reported approximately 10,675,000 kg CO2e in total emissions for 2025. This includes Scope 1 emissions of approximately 4,763,000 kg CO2e, Scope 2 emissions (market-based) of approximately 2,862,000 kg CO2e, and Scope 3 emissions. Key contributors to Scope 3 include downstream leased assets at approximately 3,050,000 kg CO2e, business travel at approximately 648,000 kg CO2e, and waste generated in operations at approximately 2,402,000 kg CO2e.

In 2024, the company's total emissions were approximately 17,314,000 kg CO2e. This comprised Scope 1 emissions of approximately 4,663,000 kg CO2e, Scope 2 emissions (market-based) of approximately 8,234,000 kg CO2e, and Scope 3 emissions, including downstream leased assets at approximately 4,417,000 kg CO2e, waste generated in operations at approximately 2,999,000 kg CO2e, and business travel at approximately 1,418,000 kg CO2e.

Ryman Healthcare is committed to significant emissions reductions, with Science-Based Targets initiative (SBTi) approved targets. The company aims to reduce absolute Scope 1 and Scope 2 greenhouse gas emissions by 42% by FY2030, from a FY2021 base year. Additionally, Ryman Healthcare commits that 75.5% of its suppliers, by spend covering purchased goods and services, capital goods, and waste generated in operations, will have science-based targets by FY2028.